PYXS

1.8107.74%
TC

Thomas Civik

CEO & Chairman

Mr. Thomas Civik, also known as Tom, is Independent Chairman of the Board at ImCheck Therapeutics SAS since March 2023. He is CEO & Chairman of Pyxis Oncology, Inc. from September 04, 2026 and serves as its Director since February 3, 2026 and was its Interim CEO since February 3, 2026 until September 04, 2026. He was Independent Director at Pyxis Oncology, Inc. since September 2021 until February 3, 2026. He serves as the Chairman of the Board at Repare Therapeutics Inc. since September 2021 and serves as its Independent Director. With a distinguished career in the biopharmaceutical industry, Mr. Civik has extensive experience in bringing oncology innovations to patients and from executive leadership roles. He served as President, Chief Executive Officer and Director at Five Prime Therapeutics, Inc. since April 13, 2020 until April 16, 2021. Mr. Civik served as a Chief Commercial Officer of Foundation Medicine, Inc. since November 2017 until September 2019. Mr. Civik built a distinguished career spanning in Genentech’s commercial organization from December 2000 to November 2017. Mr. Civik was a Vice President and Franchise Head leading the commercialization efforts for the Avastin®, Tarceva®, Alecensa® and Tecentriq® products. Prior to joining the oncology team at Genentech, he led the commercial activities for a portfolio of products focused on stroke and cardiovascular disease. Mr. Civik began is his career at Genentech in the managed care area, holding increasingly complex roles focused on delivering access for the entire Genentech portfolio. Prior to Genentech, he worked at Sanofi where he held increasing complex roles in Sales, Sales Management and Account Management from July 1992 to December 2000. As an accomplished commercial leader, he possesses a proven track record delivering strong commercial results, launching blockbuster and targeted therapies and leading large sales, marketing and market access teams. Mr. Civik holds Bachelor of Arts degree in Political Science from the Saint Norbert College and a master’s degree in business administration in business strategy and marketing from the Kellogg School of Management at Northwestern University.

Positions